Author: Willemsen, Anouk; Zwart, Mark P
Title: On the stability of sequences inserted into viral genomes Document date: 2019_11_14
ID: vv5gpldi_14
Snippet: Although live attenuated vaccines have substantially reduced rabies prevalence after oral-vaccination campaigns were conducted (Lafay et al. 1994; MacInnes et al. 2001) , such live vaccines are not efficacious in all rabies vector species. As an alternative, recombinant human adenovirus vaccine vectors expressing the rabies glycoprotein have been developed. The fitness of a replication-competent human adenovirus expressing the rabies glycoprotein.....
Document: Although live attenuated vaccines have substantially reduced rabies prevalence after oral-vaccination campaigns were conducted (Lafay et al. 1994; MacInnes et al. 2001) , such live vaccines are not efficacious in all rabies vector species. As an alternative, recombinant human adenovirus vaccine vectors expressing the rabies glycoprotein have been developed. The fitness of a replication-competent human adenovirus expressing the rabies glycoprotein was similar to that of the wild-type virus, as tested in vitro (Knowles et al. 2009 ). Moreover, the inserted rabies virus gene was stable during both in vivo and in vitro passaging (Knowles et al. 2009 ), demonstrating the potential of this recombinant vaccine vector as an effective alternative.
Search related documents:
Co phrase search for related documents- live vaccine and recombinant vaccine vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- live vaccine and vaccine vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
- live vaccine and vitro passage: 1
- live vaccine and wild type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59
- live vaccine and wild type virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- oral vaccination and vaccine vector: 1, 2, 3, 4
- oral vaccination and wild type: 1, 2, 3, 4
- oral vaccination and wild type virus: 1
- recombinant vaccine vector and vaccine vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55
- recombinant vaccine vector and wild type: 1
- recombinant vaccine vector potential and vaccine vector: 1
- substantially reduce and vaccine vector: 1
- substantially reduce and wild type: 1, 2
- substantially reduce and wild type virus: 1
- vaccine vector and wild type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- vaccine vector and wild type virus: 1, 2, 3, 4
- vitro passage and wild type: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date